AU Patent

AU770395B2 — Microfabricated devices for the delivery of molecules into a carrier fluid

Assigned to Boston Scientific Corp · Expires 2004-02-19 · 22y expired

What this patent protects

The present invention relates to a device for the controlled release of one or more drugs, comprising an implantable metallic stent and a plurality of reservoirs in the stent, wherein a therapeutic agent provided in a biodegradable or dissolvable matrix material is arranged in ea…

USPTO Abstract

The present invention relates to a device for the controlled release of one or more drugs, comprising an implantable metallic stent and a plurality of reservoirs in the stent, wherein a therapeutic agent provided in a biodegradable or dissolvable matrix material is arranged in each of the reservoirs, the matrix material degrading or dissolving in vivo to controllably release the therapeutic agent.

Drugs covered by this patent

Patent Metadata

Patent number
AU770395B2
Jurisdiction
AU
Classification
—
Expires
2004-02-19
Drug substance claim
No
Drug product claim
No
Assignee
Boston Scientific Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.